Exhibit 107
CALCULATION OF FILING FEE TABLES
Form S-8
Calithera Biosciences, Inc.
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount to be Registered(1) | Proposed Maximum Offering Price Per Share | Proposed Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||||||
Equity | 2014 Equity Incentive Plan (Common stock, $0.0001 par value per share) | Other | 3,085,761 | (2) | $ | 0.54 | (4) | $ | 1,666,310.94 | .0000927 | $ | 154.47 | ||||||||||||||
Equity | 2014 Employee Stock Purchase Plan (Common stock, $0.0001 par value per share) | Other | 250,000 | (3) | $ | 0.54 | (5) | $ | 135,000.00 | .0000927 | $ | 12.52 | ||||||||||||||
|
|
|
| |||||||||||||||||||||||
Total Offering Amounts |
| $ | 1,801,310.92 | $ | 166.99 | |||||||||||||||||||||
|
|
|
| |||||||||||||||||||||||
Total Fee Offsets |
| N/A | ||||||||||||||||||||||||
|
| |||||||||||||||||||||||||
Net Fee Due |
| $ | 166.99 | |||||||||||||||||||||||
|
|
(1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of common stock that become issuable under the above-named plans by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without receipt of consideration which results in an increase in the number of Calithera Biosciences, Inc.’s (the “Registrant”) outstanding shares of common stock, par value $0.0001 per share (the “Common Stock”). |
(2) | Represents additional shares of the Registrant’s Common Stock reserved for future grant under the Calithera Biosciences, Inc. 2014 Equity Incentive Plan (the “2014 Plan”) as a result of the automatic increase in shares reserved thereunder on January 1, 2022 pursuant to the terms of the 2014 Plan. The 2014 Plan provides that an additional number of shares will automatically be added annually to the shares authorized for issuance under the 2014 Plan on January 1, 2022 and ending on (and including) January 1, 2024 in an amount equal to 4% of the total number of shares of the Registrant’s capital stock outstanding on December 31st of the preceding calendar year, except that, before the date of any such increase, the Registrant’s board of directors may determine that the increase for such year will be a lesser number of shares. |
(3) | Represents additional shares of the Registrant’s Common Stock reserved for issuance under the Calithera Biosciences, Inc. 2014 Employee Stock Purchase Plan (the “ESPP”) as a result of the automatic increase in shares reserved thereunder on January 1, 2022 pursuant to the terms of the ESPP. The ESPP provides that an additional number of shares will automatically be added annually to the shares authorized for issuance under the ESPP on January 1, 2022 and ending on (and including) January 1, 2024. The number of shares added each year will be equal to the lesser of: (a) 1% of the total number of shares of the Registrant’s capital stock outstanding on December 31 of the preceding calendar year and (b) 250,000 shares of Common Stock, except that, before the date of any such increase, the Registrant’s board of directors may determine that there will be no such increase or that the increase for such year will be less than the amount set forth in clauses (a) and (b). |
(4) | Estimated pursuant to Rule 457(c) and Rule 457(h) solely for the purpose of calculating the registration fee on the basis of $0.54 per share, which is the average of the high and low prices of the Common Stock as reported on The Nasdaq Global Select Market on March 25, 2022, rounded up to the nearest cent. |
(5) | Estimated pursuant to Rule 457(c) and Rule 457(h) solely for the purpose of calculating the registration fee on the basis of $0.54 per share, which is 85% of the average of the high and low prices of the Common Stock as reported on The Nasdaq Global Select Market on March 25, 2022, rounded up to the nearest cent. |